These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27976897)

  • 1. Potent, Selective, Allosteric Inhibition of Human Plasmin by Sulfated Non-Saccharide Glycosaminoglycan Mimetics.
    Afosah DK; Al-Horani RA; Sankaranarayanan NV; Desai UR
    J Med Chem; 2017 Jan; 60(2):641-657. PubMed ID: 27976897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmin regulation through allosteric, sulfated, small molecules.
    Al-Horani RA; Karuturi R; White DT; Desai UR
    Molecules; 2015 Jan; 20(1):608-24. PubMed ID: 25569517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.
    Al-Horani RA; Desai UR
    Med Res Rev; 2014 Nov; 34(6):1168-216. PubMed ID: 24659483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile.
    Al-Horani RA; Karuturi R; Lee M; Afosah DK; Desai UR
    PLoS One; 2016; 11(7):e0160189. PubMed ID: 27467511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfated, low-molecular-weight lignins are potent inhibitorsof plasmin, in addition to thrombin and factor Xa: Novel opportunity for controlling complex pathologies.
    Henry BL; Abdel Aziz M; Zhou Q; Desai UR
    Thromb Haemost; 2010 Mar; 103(3):507-15. PubMed ID: 20024500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural and engineered plasmin inhibitors: applications and design strategies.
    Swedberg JE; Harris JM
    Chembiochem; 2012 Feb; 13(3):336-48. PubMed ID: 22238174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of tripeptidic plasmin inhibitors with nitrile as warhead.
    Teno N; Otsubo T; Gohda K; Wanaka K; Sueda T; Ikeda K; Hijikata-Okunomiya A; Tsuda Y
    J Pept Sci; 2012 Oct; 18(10):620-5. PubMed ID: 22961872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homogeneous, Synthetic, Non-Saccharide Glycosaminoglycan Mimetics as Potent Inhibitors of Human Cathepsin G.
    Afosah DK; Fayyad RM; Puliafico VR; Merrell S; Langmia EK; Diagne SR; Al-Horani RA; Desai UR
    Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold Attenuate Fibrinolysis in Plasma.
    Swedberg JE; Wu G; Mahatmanto T; Durek T; Caradoc-Davies TT; Whisstock JC; Law RHP; Craik DJ
    J Med Chem; 2019 Jan; 62(2):552-560. PubMed ID: 30520638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa.
    Al-Horani RA; Ponnusamy P; Mehta AY; Gailani D; Desai UR
    J Med Chem; 2013 Feb; 56(3):867-78. PubMed ID: 23316863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Heterocyclohexanone-based inhibitors of the serine protease plasmin.
    Sanders TC; Seto CT
    J Med Chem; 1999 Jul; 42(15):2969-76. PubMed ID: 10425106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Termination of bleeding by a specific, anticatalytic antibody against plasmin.
    Zhao T; Houng A; Reed GL
    J Thromb Haemost; 2019 Sep; 17(9):1461-1469. PubMed ID: 31136076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors.
    Komorowicz E; Kolev K; Machovich R
    Biochemistry; 1998 Jun; 37(25):9112-8. PubMed ID: 9636057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondin is a slow tight-binding inhibitor of plasmin.
    Hogg PJ; Stenflo J; Mosher DF
    Biochemistry; 1992 Jan; 31(1):265-9. PubMed ID: 1531022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of tenerplasminin-1, a serine peptidase inhibitor with antiplasmin activity from the coral snake (Micrurus tener tener) venom.
    Vivas J; Ibarra C; Salazar AM; Neves-Ferreira AG; Sánchez EE; Perales J; Rodríguez-Acosta A; Guerrero B
    Comp Biochem Physiol C Toxicol Pharmacol; 2016 Jan; 179():107-15. PubMed ID: 26419785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity studies of cyclic ketone inhibitors of the serine protease plasmin: design, synthesis, and biological activity.
    Xue F; Seto CT
    Bioorg Med Chem; 2006 Dec; 14(24):8467-87. PubMed ID: 16971130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on fragment-based design of allosteric inhibitors of human factor XIa.
    Boothello RS; Sankaranarayanan NV; Afosah DK; Karuturi R; Al-Horani RA; Desai UR
    Bioorg Med Chem; 2020 Dec; 28(23):115762. PubMed ID: 32992249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of a slow and tight-binding inhibitor of plasmin isolated from Russell's viper venom.
    Cheng AC; Tsai IH
    Biochim Biophys Acta; 2014 Jan; 1840(1):153-9. PubMed ID: 23999090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of plasmin activity by sulfated polyvinylalcohol-acrylate copolymers.
    Vörös G; Kolev K; Csomor K; Machovich R
    Thromb Res; 2000 Nov; 100(4):353-61. PubMed ID: 11113279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibitors of the serine protease plasmin: probing the S3 and S3' subsites using a combinatorial library.
    Xue F; Seto CT
    J Med Chem; 2005 Nov; 48(22):6908-17. PubMed ID: 16250649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.